Joel Wedd is a Gastroenterology physician. OpenAlex indexes 58 publications with 998 citations (h-index 18); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1365 Clifton Rd NE
Ste A1500
Atlanta, GA 303221013
Telephone
404-778-4271Registry record last updated 23 Jun 2014.
Clinical trials
- An Integrative Model for Palliative Care in End-Stage Liver Disease
Sponsor: Virginia Commonwealth University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
38.7%Beta blocker18.4%Carvedilol88%Nadolol12%Part D<11 patientsLoop diuretic9.8%Furosemide100%Part D≥21 patients+ 2 more classes in this area
Metabolism & gastrointestinal
35.4%Proton pump inhibitor13.2%Pantoprazole Sodium100%Part D≥19 patientsBile Acid7.2%Ursodiol100%Part D<11 patients+ 3 more classes in this area
Cancer & immunology
15.9%Calcineurin inhibitor15.9%Tacrolimus100%Part D≥25 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Prognostic Utility of Systemic Inflammatory Response Syndrome (SIRS) Criteria in Acute Alcohol-Associated Hepatitis
Digestive Diseases and Sciences
2026 - The histologic features of severe alcohol-associated hepatitis undergoing liver transplantation: An explant study
Journal of Liver Transplantation
2025 - Development and Validation of a Noninvasive Model for the Detection of High-Risk Varices in Patients With Unresectable Hepatocellular Carcinoma
Clinical Gastroenterology and Hepatology
2024 - Utility of scores to predict alcohol use after liver transplant: Take them with a grain of salt
Liver Transplantation
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Josep M. Llovet
Institució Catalana de Recerca i Estudis Avançats
Joseph J.�Y. Sung
Nanyang Technological University
Neeraj Bhala
The Royal Melbourne Hospital
Jordi Bruix
Hospital Clínic de Barcelona
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”